All News #Library
Rare Diseases
Biogen in up to $1.8 bln deal as rare diseases take center stage
23 May 2024 //
REUTERS
HI-Bio Receives FDA Orphan Designation for Felzartamab for in Kidney Transplant
21 Mar 2024 //
PR NEWSWIRE
HI-Bio Receives FDA Orphan Drug Designation for Felzartamab
25 May 2023 //
PR NEWSWIRE

Market Place
Sourcing Support